e-learning
resources
Virtual 2021
06.09.2021
Epidemiological aspects of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Particularities of people who inject drugs in a HIV-TB cohort
A. Zaharie (Bucharest, Romania), M. Tigau (Bucharest, Romania)
Source:
Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Session:
Epidemiological aspects of tuberculosis
Session type:
E-poster
Number:
2284
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Zaharie (Bucharest, Romania), M. Tigau (Bucharest, Romania). Particularities of people who inject drugs in a HIV-TB cohort. 2284
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
Revealing and prophylaxis of a tuberculosis at HIV-infected persons
Source: Eur Respir J 2006; 28: Suppl. 50, 22s
Year: 2006
Active tuberculosis case-finding among drug users and homeless persons: after the outbreak
Source: Eur Respir J 2016; 48: 269-271
Year: 2016
Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004
Particularities and challenges of TB control in homeless in Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007
Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Particularities of tuberculosis at children hospitalized with HIV co-infection
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009
High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers
Source: Eur Respir J 2015; 45: 828-831
Year: 2015
Immunologic recovery in HIV/TB co-infected patients after anti-TB treatment
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
A tuberculosis-screening program among HIV-infected patients
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
Particularities of tuberculosis in children who contacted persons discharging pathogens in Armenia
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005
Results of TB prophylactics and early detection in HIV-positive people in Moscow, Russia
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Detection of active TB among people living with HIV/AIDS and vulnerable population groups (commercial sex workers and injecting drug users)
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy
Source: ERJ Open Res, 3 (4) 00097-2017; 10.1183/23120541.00097-2017
Year: 2017
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept